Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

NCT06682195 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

TNBC, Triple Negative Breast Cancer

Interventions

DRUG: Neoadjuvant chemotherapy combined with Toripalimab

Sponsor

First Affiliated Hospital of Zhejiang University